Why the study?
Does short-term inhibition of the renin-angiotensin system alter cardiac SR Ca2+-ATPase mRNA expression in young spontaneously hypertensive rats?
Does short-term inhibition of the renin-angiotensin system alter cardiac SR Ca2+-ATPase mRNA expression in young spontaneously hypertensive rats?
In young spontaneously hypertensive rats, cardiac SR Ca2+-ATPase mRNA expression is not down-regulated and is unaffected by short-term renin-angiotensin system inhibition.
Answers are grounded in this paper and cite their sources.
Short-term RAS inhibition does not alter SR Ca2+-ATPase mRNA in young SHR; leaves open longer-term or translational effects.
Recent evidence indicates that cardiac hypertrophy induced by pressure overload is associated with a decrease in sarcoplasmic reticulum (SR) Ca2+ -ATPase of myocytes, which may contribute to a diastolic dysfunction of the heart by causing intracellular Ca2+ overload. To elucidate whether or not this is also the case in genetic hypertension, we examined cardiac mRNA levels of SR Ca2+ ATPase in 11 week old spontaneously hypertensive rats (SHR) by northern blot analysis. 2. Furthermore, to test the effects of short-term inhibition of the renin-angiotensin system on its expression, we treated 10 week old SHR with angiotensin-converting enzyme inhibitors (alacepril and imidapril) or an AT1 receptor antagonist (SC-52458) for 7 days. 3. Though the left ventricular weight of SHR was significantly higher than that of Wistar-Kyoto (WKY) rats (277 +/- 6 vs 237 +/- 4 mg/100 g bodyweight, respectively, P < 0.05), the level of SR Ca2+ -ATPase mRNA showed no difference between SHR and WKY at this age. 4. Moreover, the aforementioned three drugs did not at all affect the SR Ca2+ -ATPase expression of SHR. 5. Thus, the expression of SR Ca2+ -ATPase was not down-regulated in the heart of 11 week old SHR, and seemed not to be mediated by angiotensin AT1 receptor at this age. Since some evidence on pressure-overloaded cardiac hypertrophy indicate that the decrease in SR Ca2+ -ATPase expression occur in prominent hypertrophy and in the failured heart, further studies on cardiac SR Ca2+ -ATPase expression in more aged SHR will be required.
No takes yet. Share an insight, caveat, or question.
Ohta et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: